Ingunn Þorsteinsdottir
Reykjavik, Iceland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.
Journal: Leukemia
Published: April 22, 2026
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study.
Journal: Blood cancer journal
Published: August 27, 2024
Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia.
Journal: Archives of dermatological research
Published: July 12, 2024
Monoclonal gammopathy of undetermined significance is not associated with increased risk of skin cancer.
Journal: The British journal of dermatology
Published: July 12, 2024
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index.
Journal: Blood cancer journal
Published: June 20, 2023
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
Journal: Haematologica
Published: March 22, 2023
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening.
Journal: Nature medicine
Published: March 21, 2023
Prevalence of smoldering multiple myeloma based on nationwide screening.
Journal: Nature medicine
Published: July 07, 2022
Last Updated: 09/26/2026